Evidence map›Paper›PMID 30025394›Full record

SynthesisNeuroepidemiology2018

Presentation, Evaluation, Management, and Outcomes of Acute Stroke in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.

Rasha Khatib, Yurany A Arevalo, Mark A Berendsen, Shyam Prabhakaran, Mark D Huffman

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Neuroepidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. C-REGS2-A multinational, high-quality comparative effectiveness study of Cerebrolysin in moderate acute ischemic stroke.International journal of stroke : official journal of the International Stroke Society · 2025
    Article
  12. Article
  13. Perioperative stroke.Nature reviews. Disease primers · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Phenomic Studies on Diseases: Potential and Challenges.Phenomics (Cham, Switzerland) · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rasha KhatibDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Yurany A ArevaloDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Mark A BerendsenGalter Health Sciences Library, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Shyam PrabhakaranDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Mark D HuffmanDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Funding

Stroke Trials Network - Regional Coordinating Stroke CentersU10NS086608 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PRABHAKARAN, SHYAM · 2013 to 2017
$1.8M
NINDS NIH HHS U10 NS086608
6 · The paper itself

Abstract

aimsWe performed a systematic review to evaluate stroke presentation, evaluation, management, and outcomes among studies conducted in low- and middle-income countries (LMIC).

methodsWe searched MEDLINE (Ovid), Embase (Elsevier), and the Global Health (EBSCOhost) databases between January 2005 and June 2017 for studies conducted in LMICs defined by the World Bank. We pooled prevalence estimates using an inverse-variance weighting method and stratified by the country income group.

resultsThe search identified 36 hospital-based studies (64,256 participants) in LMICs. Mean (SD) age ranged from 51 (14) to 72 (12) years, and 29-56% of patients were women. Hypertension was the most commonly reported risk factor (64% [95% CI 59-69]). In settings where MRI was not used, head CT scans were reported among 90% patients (95% CI 79-97). Overall, 3% (95% CI 2-4) of patients were treated with tissue plasminogen activator, and 78% (95% CI 66-88) were treated with antiplatelet therapy. Overall, the rate of in-hospital mortality was 14% (95% CI 10-19), and the rate of in-hospital pneumonia was 17% (95% CI 14-20).

conclusionsOur review revealed the low use of evidence-based practices for acute stroke care in LMIC. The true use in hospitals that do not conduct this research is probably even lower. Strategies to evaluate and improve health system performance for acute stroke care, including implantation of stroke units and making thrombolysis more available and affordable are needed in LMIC. Registration in Prospero: CRD42017069325.

Indexed as

BrainDeveloping CountriesFibrinolytic AgentsGlobal HealthHumansMagnetic Resonance ImagingRisk FactorsStrokeTissue Plasminogen ActivatorTreatment OutcomeFibrinolytic AgentsTissue Plasminogen ActivatorAcute careEvidence-based practiceIn-hospital mortalityLow- and middle-income countriesMeta-analysisStroke

Identifiers

PMID30025394
PMCPMC6322558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.